BNP Paribas Financial Markets’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7K | Buy |
5,770
+1,852
| +47% | +$5.35K | ﹤0.01% | 3865 |
|
|
2025
Q1 | $8.42K | Sell |
3,918
-2,547
| -39% | -$5.48K | ﹤0.01% | 3926 |
|
|
2024
Q4 | $25K | Buy |
+6,465
| New | +$25K | ﹤0.01% | 3819 |
|
|
2020
Q2 | – | Sell |
-7
| Closed | -$67 | – | 3705 |
|
|
2020
Q1 | $67 | Hold |
7
| – | – | ﹤0.01% | 3612 |
|
|
2019
Q4 | $97 | Sell |
7
-303
| -98% | -$4.2K | ﹤0.01% | 3661 |
|
|
2019
Q3 | $2.75K | Hold |
310
| – | – | ﹤0.01% | 3691 |
|
|
2019
Q2 | $4.42K | Sell |
310
-245
| -44% | -$3.5K | ﹤0.01% | 3631 |
|
|
2019
Q1 | $18.2K | Buy |
555
+531
| +2,213% | +$17.5K | ﹤0.01% | 3329 |
|
|
2018
Q4 | $1.43K | Sell |
24
-38
| -61% | -$2.26K | ﹤0.01% | 3186 |
|
|
2018
Q3 | $8.72K | Sell |
62
-1
| -2% | -$141 | ﹤0.01% | 3135 |
|
|
2018
Q2 | $7.7K | Buy |
63
+62
| +6,200% | +$7.58K | ﹤0.01% | 3254 |
|
|
2018
Q1 | $45 | Hold |
1
| – | – | ﹤0.01% | 3568 |
|
|
2017
Q4 | $28 | Hold |
1
| – | – | ﹤0.01% | 3488 |
|
|
2017
Q3 | $21 | Hold |
1
| – | – | ﹤0.01% | 3519 |
|
|
2017
Q2 | $21 | Sell |
1
-15
| -94% | -$315 | ﹤0.01% | 3558 |
|
|
2017
Q1 | $909 | Sell |
16
-18
| -53% | -$1.02K | ﹤0.01% | 3136 |
|
|
2016
Q4 | $1.29K | Sell |
34
-96
| -74% | -$3.65K | ﹤0.01% | 3341 |
|
|
2016
Q3 | $5.14K | Buy |
130
+55
| +73% | +$2.18K | ﹤0.01% | 3379 |
|
|
2016
Q2 | $5.42K | Buy |
75
+32
| +74% | +$2.31K | ﹤0.01% | 3238 |
|
|
2016
Q1 | $3.44K | Sell |
43
-291
| -87% | -$23.3K | ﹤0.01% | 2329 |
|
|
2015
Q4 | $25.2K | Buy |
334
+41
| +14% | +$3.09K | ﹤0.01% | 3211 |
|
|
2015
Q3 | $112K | Buy |
293
+12
| +4% | +$4.59K | ﹤0.01% | 2321 |
|
|
2015
Q2 | $117K | Buy |
281
+185
| +193% | +$76.9K | ﹤0.01% | 1998 |
|
|
2015
Q1 | $45.4K | Buy |
+96
| New | +$45.4K | ﹤0.01% | 1967 |
|